AntriaBio (OTC:ANTB) said today that it closed a $13 million private placement, supported by Aju Pharm, Ildong Pharmaceutical Co. and Medici Investment Co.
According to the deal, investors paid $1.00 per share of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post AntriaBio raises $13m for injectable, once-weekly insulin appeared first on MassDevice.